Trulieve Cannabis logo

TRUL - Trulieve Cannabis Share Price

C$51.17 -0.3  -0.5%

Last Trade - 09/04/21

Large Cap
Market Cap £3.56bn
Enterprise Value £3.64bn
Revenue £380.5m
Position in Universe 105th / 2707
Unlock TRUL Revenue
Relative Strength (%)
1m -13.8%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -24.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 19.8 102.8 252.8 521.5 709.7 1,013 +1,684%
+15.6 +116.4 +82.3
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, TrulieveCannabis Corp revenues increased from $252.8M to $521.5M.Net income increased 19% to $63M. Revenues reflect anincrease in demand for the Company's products and servicesdue to favorable market conditions. Net income waspartially offset by Interest Expense increase from $9.1M to$20.2M (expense), Depreciation and Amortization increasefrom $5.1M to $12.6M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for TRUL
Graphical History


TRUL Revenue Unlock TRUL Revenue

Net Income

TRUL Net Income Unlock TRUL Revenue

Normalised EPS

TRUL Normalised EPS Unlock TRUL Revenue

PE Ratio Range

TRUL PE Ratio Range Unlock TRUL Revenue

Dividend Yield Range

TRUL Dividend Yield Range Unlock TRUL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
TRUL EPS Forecasts Unlock TRUL Revenue
Profile Summary

Trulieve Cannabis Corp is a Canada-based seed to sale licensed medical cannabis company. The Company cultivates and produces all of its products in-house and distributes those products to Trulieve branded stores (dispensaries), as well as directly to patients through home delivery. It also operates in California, Massachusetts and Connecticut. The Company offers a range of products, such as concentrates, flower, oil, capsules and tinctures. It operates a 35,000 square foot cultivation and processing facility in McKeesport, Pennsylvania. It operates three dispensaries, located in Pittsburgh-area locations and also offers medical marijuana relief solutions for Pennsylvanians certified with serious medical conditions. The Company's subsidiaries include PurePenn LLC, Pioneer Leasing & Consulting LLC and Keystone Relief Centers LLC.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Public Since September 25, 2018
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Pharmaceuticals
Exchange Canadian Securities Exchange
Shares in Issue 119,573,998
Free Float (0.0%)
Eligible for
TRUL Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for TRUL
Upcoming Events for TRUL
Tuesday 18th May, 2021 Estimate
Q1 2021 Trulieve Cannabis Corp Earnings Release
Tuesday 10th August, 2021 Estimate
Q2 2021 Trulieve Cannabis Corp Earnings Release
Frequently Asked Questions for Trulieve Cannabis
What is the Trulieve Cannabis share price?

As of 09/04/21, shares in Trulieve Cannabis are trading at C$51.17, giving the company a market capitalisation of £3.56bn. This share price information is delayed by 15 minutes.

How has the Trulieve Cannabis share price performed this year?

Shares in Trulieve Cannabis are currently trading at C$51.17 and the price has moved by 0.277k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Trulieve Cannabis price has moved by 0.176k% over the past year.

What are the analyst and broker recommendations for Trulieve Cannabis?

Of the analysts with advisory recommendations for Trulieve Cannabis, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Trulieve Cannabis is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Trulieve Cannabis next release its financial results?

Trulieve Cannabis is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Trulieve Cannabis dividend yield?

Trulieve Cannabis does not currently pay a dividend.

Does Trulieve Cannabis pay a dividend?

Trulieve Cannabis does not currently pay a dividend.

When does Trulieve Cannabis next pay dividends?

Trulieve Cannabis does not currently pay a dividend.

How do I buy Trulieve Cannabis shares?

To buy shares in Trulieve Cannabis you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Trulieve Cannabis?

Shares in Trulieve Cannabis are currently trading at C$51.17, giving the company a market capitalisation of £3.56bn.

Where are Trulieve Cannabis shares listed? Where are Trulieve Cannabis shares listed?

Here are the trading details for Trulieve Cannabis:

Country of listing: Canada
Exchange: CNX
Ticker Symbol: TRUL
What kind of share is Trulieve Cannabis?

Based on an overall assessment of its quality, value and momentum, Trulieve Cannabis is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Trulieve Cannabis share price forecast 2021?

Shares in Trulieve Cannabis are currently priced at C$51.17. At that level they are trading at 16.2% premium to the analyst consensus target price of 0.00.

Analysts covering Trulieve Cannabis currently have a consensus Earnings Per Share (EPS) forecast of 1.152 for the next financial year.

How can I tell whether the Trulieve Cannabis share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Trulieve Cannabis. Over the past six months, the relative strength of its shares against the market has been 56.58%. At the current price of C$51.17, shares in Trulieve Cannabis are trading at 32.96% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Trulieve Cannabis PE Ratio?

The Trulieve Cannabis PE ratio based on its reported earnings over the past 12 months is 76.72. The shares are currently trading at C$51.17.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Trulieve Cannabis?

Trulieve Cannabis's management team is headed by:

Kim Rivers - CHM
Mohan Srinivasan - CFO
Jason Pernell - CIO
Timothy Morey - OTH
Kyle Landrum - OTH
Valda Coryat - CMO
Steven Ferrell - DHR
Thad Beshears - IND
George Hackney - IND
Richard May - IND
Michael O Donnell - IND
Peter Healy - DRC
Ronda Sheffield - CHO
Zachary Kobrin - GCN
Aaron Lopez - OTH
Who are the major shareholders of Trulieve Cannabis?

Here are the top five shareholders of Trulieve Cannabis based on the size of their shareholding:

Beshears (Thad) Individual Investor
Percentage owned: 1.94% (2.42m shares)
O'Donnell (Michael Jay) Individual Investor
Percentage owned: 0.71% (883k shares)
May (Richard Suber) Individual Investor
Percentage owned: 0.36% (448k shares)
Hackney (George) Individual Investor
Percentage owned: 0.23% (282k shares)
AdvisorShares Pure Cannabis ETF Mutual Fund
Percentage owned: 0.19% (235k shares)
Similar to TRUL
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.